Individual DNA passport could result in fewer drug side effects

You may be required to show a DNA passport when you pick up medicines at the pharmacy in the future. According to a new study, patients might suffer 30% fewer s...

Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...

This is how Anette Steenberg will put Medicon Valley on the world map

Anette Steenberg has been CEO of the Swedish-Danish life science cluster Medicon Valley Alliance since 1 November last year. Life Science Sweden called her to a...

“Photon counting in computed tomography is the holy grail”

Erik Fredenberg, a researcher in physics at KTH and GE, is working to implement photon-counting CT in clinics. To shorten lead times and reduce the radiation do...

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Astra Zeneca fick Swecares exportpris – ”Fenomenalt stark utveckling”

Ett globalt storbolag och en uppstickare delar på Swecare Export Awards 2024. Årets vinnare: läkemedelsjätten Astra Zeneca och sårvårdsbolaget PU sensor.

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

He is zooming in on topical preparations

According to Zelmic CEO David Sagna, topical products in drug development is a growing market, and to keep pace with the development, the company is awaiting approval for its new...

Precision and accuracy in liquid handling

How to evaluate and optimize liquid handling performance

Kancera gör nyemission och ingår licensavtal om hjärtinfarktsbehandling

Forskningsbolaget Kancera har ingått ett licensavtal om de globala rättigheterna till studieresultat kring företagets läkemedelskandidat för behandling av patie...

FOKUS Patient turns international

FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.

Vikarierande generaldirektör ny ordförande för Vårdanalys

Den tillförordnade generaldirektören för Sveriges geologiska undersökning ska nu leda Vårdanalys styrelse.

Alert from the Swedish Medicines Agency: Many complications with gastric balloons

According to the Swedish Medicines Agency, an increasing number of serious complications are being reported in procedures with gastric balloons as a method for ...

Fördjupat samarbete ska stärka Göteborgs life science-kluster

Göteborg är hemvist för ett av de största hälso-klustren i Norden – men vill växa och bli ännu vassare. Nu inleder Astra Zeneca och Business Region Göteborg ett...

New study: Post-Covid symptoms are common even after mild Covid-19

According to researchers at the University of Gothenburg, loss of smell and taste, shortness of breath and chest symptoms are the most common complaints after a...

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Så mycket väntas lecanemab sälja globalt

Försäljningen av Leqembi (lecanemab), som nyligen fick ett accelererat USA-godkännande som behandling mot Alzheimers sjukdom, väntas globalt uppgå till sju milj...

Marie Gårdmark: Potential step change – EU regulators get to play with data

A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approval for new medicines. Marie Grådmark writes in a column that she is looking forward...

Mpox till Sverige – första fallet av dödligare varianten bekräftad

Fallet i Region Stockholm är det första som diagnosticerats utanför den afrikanska kontinenten.

International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...

Bältrosvaccin undersöks som potentiellt skydd mot demens

Brittiska Glaxo Smith Kline undersöker om bolagets storsäljande vaccin mot bältros även minskar risken för demens.

Överväger likvidation efter nedlagd studie – "Vi är mycket besvikna"

Utvecklingen av läkemedelskandidaten cobitolimod läggs ned och företaget bakom – Solnabaserade Index Pharmaceuticals – överväger att gå i likvidation.

Pharma Outsourcing igång på Stockholm Waterfront

Ny ordförande för Atlas Antibodies

Åsa Riisberg, styrelseproffs och tidigare partner i EQT, tar över ordförandeklubban i Atlas Antibodies.